BIOMAT Database Logo BIOMAT Database Logo

Structure-activity relationship within a series of okadaic acid derivatives. 1990

S Nishiwaki, and H Fujiki, and M Suganuma, and H Furuya-Suguri, and R Matsushima, and Y Iida, and M Ojika, and K Yamada, and D Uemura, and T Yasumoto
Cancer Prevention Division, National Cancer Center Research Institute, Tokyo, Japan.

Okadaic acid (OA) is a potent non-12-O-tetradecanoyl-phorbol-13-acetate (non-TPA) type tumor promoter on mouse skin. OA acts on cells through inhibiting the activity of protein phosphatases and results in the increase of phosphorylation of proteins. Seventeen OA derivatives were evaluated as possible tumor promoters by means of three biochemical tests: inhibition of specific [3H]OA binding to a particulate fraction of mouse skin containing protein phosphatases, inhibition of protein phosphatase activity, and induction of ornithine decarboxylase in mouse skin. Potency in each of these biochemical tests correlated well for each of these derivatives. We present results indicating that the carboxyl group as well as the four hydroxyl groups at C-2, C-7, C-24 and C-27 of OA are important for activity. Acanthifolicin, which gave positive responses in these three biochemical tests as strong as those of OA and dinophysistoxin-1, is predicted to be an additional member of the OA class of tumor promoters.

UI MeSH Term Description Entries
D009955 Ornithine Decarboxylase A pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. It catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine. Ornithine Carboxy-lyase,Carboxy-lyase, Ornithine,Decarboxylase, Ornithine,Ornithine Carboxy lyase
D010749 Phosphoprotein Phosphatases A group of enzymes removing the SERINE- or THREONINE-bound phosphate groups from a wide range of phosphoproteins, including a number of enzymes which have been phosphorylated under the action of a kinase. (Enzyme Nomenclature, 1992) Phosphoprotein Phosphatase,Phosphoprotein Phosphohydrolase,Protein Phosphatase,Protein Phosphatases,Casein Phosphatase,Ecto-Phosphoprotein Phosphatase,Nuclear Protein Phosphatase,Phosphohistone Phosphatase,Phosphoprotein Phosphatase-2C,Phosphoseryl-Protein Phosphatase,Protein Phosphatase C,Protein Phosphatase C-I,Protein Phosphatase C-II,Protein Phosphatase H-II,Protein-Serine-Threonine Phosphatase,Protein-Threonine Phosphatase,Serine-Threonine Phosphatase,Threonine Phosphatase,Ecto Phosphoprotein Phosphatase,Phosphatase C, Protein,Phosphatase C-I, Protein,Phosphatase C-II, Protein,Phosphatase H-II, Protein,Phosphatase, Casein,Phosphatase, Ecto-Phosphoprotein,Phosphatase, Nuclear Protein,Phosphatase, Phosphohistone,Phosphatase, Phosphoprotein,Phosphatase, Phosphoseryl-Protein,Phosphatase, Protein,Phosphatase, Protein-Serine-Threonine,Phosphatase, Protein-Threonine,Phosphatase, Serine-Threonine,Phosphatase, Threonine,Phosphatase-2C, Phosphoprotein,Phosphatases, Phosphoprotein,Phosphatases, Protein,Phosphohydrolase, Phosphoprotein,Phosphoprotein Phosphatase 2C,Phosphoseryl Protein Phosphatase,Protein Phosphatase C I,Protein Phosphatase C II,Protein Phosphatase H II,Protein Phosphatase, Nuclear,Protein Serine Threonine Phosphatase,Protein Threonine Phosphatase,Serine Threonine Phosphatase
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004988 Ethers, Cyclic Compounds of the general formula R-O-R arranged in a ring or crown formation. Cyclic Ether,Cyclic Ethers,Ether, Cyclic
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

S Nishiwaki, and H Fujiki, and M Suganuma, and H Furuya-Suguri, and R Matsushima, and Y Iida, and M Ojika, and K Yamada, and D Uemura, and T Yasumoto
Structure-activity relationship within a series of m-diaminobenzene derivatives.
May 1980, Mutation research,
S Nishiwaki, and H Fujiki, and M Suganuma, and H Furuya-Suguri, and R Matsushima, and Y Iida, and M Ojika, and K Yamada, and D Uemura, and T Yasumoto
Inhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationship.
June 1992, The Biochemical journal,
S Nishiwaki, and H Fujiki, and M Suganuma, and H Furuya-Suguri, and R Matsushima, and Y Iida, and M Ojika, and K Yamada, and D Uemura, and T Yasumoto
Structure-activity relationships within various series of p-phenylenediamine derivatives.
May 1994, Mutation research,
S Nishiwaki, and H Fujiki, and M Suganuma, and H Furuya-Suguri, and R Matsushima, and Y Iida, and M Ojika, and K Yamada, and D Uemura, and T Yasumoto
Structure-activity relationship within a series of degradation products of tautomycin.
January 1996, Bioscience, biotechnology, and biochemistry,
S Nishiwaki, and H Fujiki, and M Suganuma, and H Furuya-Suguri, and R Matsushima, and Y Iida, and M Ojika, and K Yamada, and D Uemura, and T Yasumoto
Structure-activity relationship in carbanilic acid derivatives.
January 1986, Drugs under experimental and clinical research,
S Nishiwaki, and H Fujiki, and M Suganuma, and H Furuya-Suguri, and R Matsushima, and Y Iida, and M Ojika, and K Yamada, and D Uemura, and T Yasumoto
Hypoglycaemic activity and structure activity relationship of a new series of sulphonylurea derivatives.
July 1971, Arzneimittel-Forschung,
S Nishiwaki, and H Fujiki, and M Suganuma, and H Furuya-Suguri, and R Matsushima, and Y Iida, and M Ojika, and K Yamada, and D Uemura, and T Yasumoto
Structure-Activity Relationship Studies Using Natural and Synthetic Okadaic Acid/Dinophysistoxin Toxins.
November 2016, Marine drugs,
S Nishiwaki, and H Fujiki, and M Suganuma, and H Furuya-Suguri, and R Matsushima, and Y Iida, and M Ojika, and K Yamada, and D Uemura, and T Yasumoto
Structure-antifungal activity relationship of cinnamic acid derivatives.
December 2007, Journal of agricultural and food chemistry,
S Nishiwaki, and H Fujiki, and M Suganuma, and H Furuya-Suguri, and R Matsushima, and Y Iida, and M Ojika, and K Yamada, and D Uemura, and T Yasumoto
Antibacterial Activity and Structure-Activity Relationship of a Series of Newly Synthesized Pleuromutilin Derivatives.
February 2019, Chemistry & biodiversity,
S Nishiwaki, and H Fujiki, and M Suganuma, and H Furuya-Suguri, and R Matsushima, and Y Iida, and M Ojika, and K Yamada, and D Uemura, and T Yasumoto
Anti-influenza A virus activity and structure-activity relationship of a series of nitrobenzoxadiazole derivatives.
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!